Browse Category

Stock Market News 9 December 2025

Cisco Stock (CSCO) Tests $80 Resistance as AI Demand Surges: Latest News, Analyst Ratings and Price Forecasts – December 9, 2025

Cisco Stock (CSCO) Tests $80 Resistance as AI Demand Surges: Latest News, Analyst Ratings and Price Forecasts – December 9, 2025

Cisco Systems, Inc. (NASDAQ: CSCO) remains firmly in the market spotlight on December 9, 2025, as its share price pushes up against the psychologically important $80 resistance level while Wall Street continues to re-rate the networking giant on the back of strong AI-related demand. As of late trading on Tuesday, Cisco stock trades around $79.70, up roughly 1.1% on the day, after opening near $78.79 and touching an intraday high of $79.88. The move extends a powerful rally that has left CSCO up about 38% year-to-date in 2025, outpacing the broader S&P 500.Yahoo Finance Below is a detailed, news-driven breakdown
9 December 2025
AST SpaceMobile (ASTS) Stock on December 9, 2025: Insider Sales, BlueBird 6 Launch and Wild Volatility Ahead of a Make‑or‑Break Year

AST SpaceMobile (ASTS) Stock on December 9, 2025: Insider Sales, BlueBird 6 Launch and Wild Volatility Ahead of a Make‑or‑Break Year

AST SpaceMobile, Inc. (NASDAQ: ASTS) has become one of 2025’s most explosive – and controversial – space stocks. As of December 9, 2025, shares are trading around $73–74, up well over 200% year‑to‑date, yet still well below their recent 12‑month high above $100. MarketBeat+1 At the same time, new insider sales, a looming BlueBird 6 launch on December 15, and sharply divided analyst opinions are turning ASTS into a battleground between growth optimists and valuation skeptics. Below is a structured look at everything investors following AST SpaceMobile need to know today, December 9, 2025, including the latest news, forecasts and
9 December 2025
Nebius Group N.V. (NBIS) Stock Outlook for 2026: How Microsoft and Meta Deals Are Shaping This AI Infrastructure High‑Flier

Nebius Group N.V. (NBIS) Stock Outlook for 2026: How Microsoft and Meta Deals Are Shaping This AI Infrastructure High‑Flier

Updated: December 9, 2025 – All figures and news as of this date. This article is for information only and is not investment advice. Nebius at a Glance: A Hypergrowth AI Cloud Stock With Big Deals and Bigger Risks Nebius Group N.V. (NASDAQ: NBIS) has become one of the most talked‑about AI infrastructure stocks of 2025. As of the afternoon of December 9, 2025, Nebius trades around $97–$100 per share, giving the company a market capitalization of roughly $24–25 billion. The stock is up about 200–250% in 2025, yet it sits roughly 31% below its 52‑week high of $141.10, highlighting
9 December 2025
Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits

Medline IPO 2025: Inside the $5.37 Billion Nasdaq Listing and One of Private Equity’s Biggest Exits

NEW YORK / NORTHFIELD, Ill. — December 9, 2025 — Medical‑supply giant Medline Inc. has set the terms for a U.S. initial public offering that could raise up to $5.37 billion and value the company at as much as $55.3 billion, positioning it as the largest U.S. IPO of 2025 and one of the biggest private‑equity‑backed listings on record.Reuters+1 The Illinois‑based manufacturer and distributor of medical‑surgical supplies plans to sell 179 million shares on the Nasdaq under the ticker MDLN at a price range of $26 to $30 per share, with Goldman Sachs, Morgan Stanley, BofA Securities and J.P. Morgan
9 December 2025
Trump Administration’s Deal to End SAVE Student Loan Plan: What the December 9 Settlement Means for Millions of Borrowers

Trump Administration’s Deal to End SAVE Student Loan Plan: What the December 9 Settlement Means for Millions of Borrowers

Dateline: Washington, D.C. — December 9, 2025 The federal student loan system is facing yet another seismic shift. On December 9, 2025, the U.S. Department of Education and the state of Missouri announced a proposed court settlement that would effectively terminate the Biden‑era Saving on a Valuable Education (SAVE) income‑driven repayment plan, leaving more than 7 million borrowers to navigate a new and still‑uncertain repayment landscape. The Washington Post+1 At the same time, Trump administration officials signaled their intent to end the special payment pause and forbearance protections that had shielded millions of SAVE borrowers from monthly bills for roughly
9 December 2025
Accenture (ACN) Stock Today: Anthropic AI Deal, Insider Buying and 2026 Forecasts — December 9, 2025

Accenture (ACN) Stock Today: Anthropic AI Deal, Insider Buying and 2026 Forecasts — December 9, 2025

Accenture plc (NYSE: ACN) is back in the AI spotlight on December 9, 2025. The shares are trading around $269–270 after a brutal year that saw the stock fall roughly 30–40% from its February peak, even as the company delivered record bookings and doubled down on generative AI. linkedin.com+2Barchart.com+2 Today’s main catalyst: a multi‑year partnership with Anthropic, fresh evidence of institutional and insider buying, and a growing chorus of analysts arguing that Accenture’s AI “reinvention” may finally be mispriced in investors’ favor. Seeking Alpha+3Reuters+3GuruFocus+3 Accenture stock on 9 December 2025: price, performance and valuation As of the latest trade on
Ciena (CIEN) Stock Hits Record High on AI Network Boom: New $230–$240 Price Targets and Q4 2025 Earnings Preview

Ciena (CIEN) Stock Hits Record High on AI Network Boom: New $230–$240 Price Targets and Q4 2025 Earnings Preview

Updated December 9, 2025 – For informational purposes only, not investment advice. Ciena stock today: fresh 52‑week high and triple‑digit gains Ciena Corporation (NYSE: CIEN) is closing 2025 on a dramatic high note. On December 9, 2025, CIEN pushed to a new 52‑week intraday high around $219.88, up from a 12‑month low near $49.21. That’s a roughly 4.5x move off the bottom and a ~180%+ gain over the last year, according to data from Angel One and Investing.com. Angel One+1 Ciena last closed at $212.93 on December 8, up 5.56% on the day, with a market capitalization of about $30–31
Applied Digital (APLD) Stock Soars Over 270%: Can the AI Data Center High‑Flyer Keep Climbing in 2026?

Applied Digital (APLD) Stock Soars Over 270%: Can the AI Data Center High‑Flyer Keep Climbing in 2026?

As of December 9, 2025, Applied Digital Corporation (NASDAQ: APLD) has turned into one of the most explosive names in the AI infrastructure trade — and also one of the most controversial. The stock trades around $33 per share, up roughly 3% on the day, giving Applied Digital a market cap near $9–9.5 billion on trailing twelve‑month revenue of about $174 million. Its 52‑week range runs from $3.31 to $40.20, and its beta above 7 makes it one of the most volatile tech names on the market. StockAnalysis Over the past year, APLD has surged roughly 270%–350% depending on the
CRH PLC Stock Surges Toward S&P 500 Debut: Record Highs, Buybacks and 2026 Outlook Explained

CRH PLC Stock Surges Toward S&P 500 Debut: Record Highs, Buybacks and 2026 Outlook Explained

As of 9 December 2025 CRH stock today: near record highs ahead of S&P 500 entry CRH plc (NYSE: CRH), the building‑materials giant, is trading just below fresh record levels as investors position for its upcoming inclusion in the S&P 500 index. On 9 December 2025, CRH ADRs changed hands around $125–126, after touching a new all‑time high of $126.96 on 8 December. Over the past year the stock has gained around 26%, and nearly 30% in the last six months, comfortably outpacing the broader market. Investing.com+1 Technically, the momentum is strong. Investor’s Business Daily reports that CRH’s Relative Strength
9 December 2025
Lam Research (LRCX) Stock Today: AI Chip Tailwinds, Fresh Analyst Targets and December 9, 2025 Forecast

Lam Research (LRCX) Stock Today: AI Chip Tailwinds, Fresh Analyst Targets and December 9, 2025 Forecast

Lam Research Corporation (NASDAQ: LRCX) continues to ride the artificial intelligence (AI) chip boom, and as of December 9, 2025, its stock is trading near record levels after a year of explosive gains, upbeat guidance, and a wave of institutional buying. LRCX Stock Snapshot on December 9, 2025 Lam Research shares recently changed hands around $164.90, up about 1.3% on the day, putting the stock just below its 52‑week high in the mid‑$160s.StockInvest Over the past 12 months, the stock has delivered a total return of roughly 125–130%, far outpacing the S&P 500’s low‑teens gain.Finimize+1Other key markers: Lam also pays
Rigetti Computing (RGTI) Stock News Today: DARPA Setback, Citadel Buying and 2026–2030 Forecasts

Rigetti Computing (RGTI) Stock News Today: DARPA Setback, Citadel Buying and 2026–2030 Forecasts

As of December 9, 2025, Rigetti Computing, Inc. (NASDAQ: RGTI) remains one of the wildest rides in quantum computing. The stock is trading around $27–28 per share, with intraday moves between roughly $26.9 and $28.2, implying a market cap just under $10 billion on trailing 12‑month revenue of only about $7.5 million. StockAnalysis Over the past year, Rigetti’s share price has gone parabolic and then some—up roughly 586% over the last 52 weeks by one hedge fund’s tally and around 3,750% since January 2023—yet the stock also collapsed about 42% in November after a messy third‑quarter report and a harsh
Disney Stock (DIS) on December 9, 2025: Big-Money Moves, Q4 Fallout and 2026–2028 Forecasts

Disney Stock (DIS) on December 9, 2025: Big-Money Moves, Q4 Fallout and 2026–2028 Forecasts

Ticker: NYSE: DISDate: December 9, 2025 The Walt Disney Company’s stock is trading in a tight range just above key support as Wall Street digests mixed fiscal 2025 results, a looming YouTube TV dispute and fresh analyst forecasts that still point to double‑digit earnings growth over the next few years. Disney stock price and valuation today As of late trading on December 9, 2025, Disney shares change hands at about $107 per share, down roughly 0.5% on the day, after opening near $107.50 and trading between about $106.6 and $107.9. Key valuation and balance‑sheet metrics from recent filings and analyst
Snowflake (SNOW) Stock on December 9, 2025: Is the Post‑Earnings Dip a Buying Opportunity?

Snowflake (SNOW) Stock on December 9, 2025: Is the Post‑Earnings Dip a Buying Opportunity?

Snowflake Inc. (NYSE: SNOW) has spent the past week digesting a sharp post‑earnings sell‑off, even as its AI‑driven growth story and free‑cash‑flow (FCF) guidance continue to impress Wall Street. As of late trading on December 9, 2025, Snowflake shares change hands around $222 per share, giving the company a market capitalization in the mid‑$70 billion range.MacroTrends+1 That’s roughly 15–20% below last week’s pre‑earnings high near $265, but still leaves the stock up strongly for 2025 — more than 60–70% year to date, according to multiple reports.Reuters+1 Below is a comprehensive look at today’s key news (09.12.2025), recent earnings, analyst forecasts,
CrowdStrike Stock (CRWD) on December 9, 2025: Price Action, AI Deals, Analyst Targets and 2026 Outlook

CrowdStrike Stock (CRWD) on December 9, 2025: Price Action, AI Deals, Analyst Targets and 2026 Outlook

CrowdStrike Holdings, Inc. (NASDAQ: CRWD) continues to sit at the center of three powerful themes on December 9, 2025: cybersecurity, artificial intelligence and cloud infrastructure. The stock is back above the $520 mark after a volatile reaction to its latest earnings report, while Wall Street keeps raising price targets even as some traders warn about stretched valuations. Below is a full rundown of where the stock stands today, what just happened in Q3, and how major analysts and institutions see CrowdStrike heading into 2026. Where CrowdStrike Stock Trades Today In early afternoon trading on December 9, 2025, CrowdStrike shares change
Chevron (CVX) Stock on December 9, 2025: Latest News, Analyst Forecasts, Dividend and 2030 Outlook

Chevron (CVX) Stock on December 9, 2025: Latest News, Analyst Forecasts, Dividend and 2030 Outlook

Published: December 9, 2025 Chevron Corporation (NYSE: CVX) traded around $148–$149 per share on Tuesday, down fractionally on the day, leaving the oil major roughly in the middle of its 52‑week range of $132 to $169. At this level, the stock carries a price‑to‑earnings ratio near 21, a dividend yield of about 4.6%, and a market capitalization just under $300 billion. Benzinga+1 Investors today are digesting fresh 2026 capital‑spending guidance, a detailed 2030 cash‑flow roadmap, new upstream projects in Australia and Nigeria, and ongoing integration of the $55 billion Hess acquisition, all against a backdrop of mixed short‑term technical signals
Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

Walmart (WMT) Stock on December 9, 2025: Nasdaq Debut, Tech Pivot and 2026 Outlook

On December 9, 2025, Walmart Inc. stock begins trading on the Nasdaq, capping a year in which the world’s largest retailer by revenue has quietly turned into one of Wall Street’s favorite “tech‑adjacent” growth stories. With WMT hovering around $114 per share, a market value of roughly $910 billion and a price‑to‑earnings multiple near 40x, investors are asking the same question: how much of Walmart’s future is already priced in – and what comes next for the stock? StockAnalysis+1 Walmart stock today: price, valuation and trading range As of mid‑day trading on December 9, 2025, Walmart (ticker: WMT) is changing
9 December 2025
Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson Stock Today: Q3 Beat, Orthopaedics Spin-Off and New Cancer Data Power a 40% Rally

Johnson & Johnson stock (NYSE: JNJ) has quietly turned into one of 2025’s standout blue‑chip winners. As of December 9, 2025, JNJ trades around $202 per share, valuing the company at roughly $486 billion and leaving the stock up close to 40% year to date.Trefis+1 That move reflects more than just a defensive bid for a safe dividend name. Investors are reacting to a powerful combination of: Below is a detailed, news‑driven look at what’s moving Johnson & Johnson stock on December 9, 2025, and how Wall Street currently values and forecasts JNJ. Johnson & Johnson stock today: price, performance
Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce (CRM) Stock on December 9, 2025: Q3 FY26 Beat, AI Agentforce Momentum and What Comes Next

Salesforce, Inc. (NYSE: CRM) is back in the spotlight after reporting record fiscal Q3 2026 results, raising its full‑year outlook, and drawing a wave of analyst and institutional attention. As of December 9, 2025, Salesforce stock is trading around $260 per share, recovering sharply from recent lows but still well below its 52‑week high. MarketBeat This article pulls together all the key news, forecasts and analyses available on December 9, 2025 to give you a current, Google‑News‑ready view of Salesforce’s stock story — from AI and Agentforce to price targets, insider trades, dividends and risks. Salesforce stock price today: CRM
JPMorgan Chase (JPM) Stock in December 2025: Price, Latest News, Analyst Forecasts and Key Risks

JPMorgan Chase (JPM) Stock in December 2025: Price, Latest News, Analyst Forecasts and Key Risks

JPMorgan Chase & Co. (NYSE: JPM) is ending 2025 near record highs and at the center of several major strategic moves – from a $1.5 trillion national‑security financing push to mutual‑fund‑to‑ETF conversions and a landmark crypto IPO mandate. Here’s a detailed look at where JPM stock stands on 9 December 2025, what the latest news means, and how Wall Street is valuing the world’s largest U.S. bank. 1. JPMorgan Chase Stock Today: Price, Valuation and Performance As of the latest real‑time data on 9 December 2025, JPMorgan Chase trades around $317 per share, with the prior close at $315.21. The
9 December 2025
Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma (ASND) Stock Slides After Q3 Miss and FDA Delay – What Investors Need to Know on December 9, 2025

Ascendis Pharma A/S (NASDAQ: ASND) is back in the spotlight on December 9, 2025, after its share price slipped again while Wall Street continues to project hefty upside and label the name a “Buy” or “Strong Buy.” The Danish biotech, known for its TransCon long-acting prodrug platform and endocrine rare disease franchise, is wrestling with three forces at once: Let’s unpack what’s going on with Ascendis Pharma stock today, how the story changed in recent weeks, and what current forecasts say about where ASND could go next. ASND stock today: price action and context By late trading on December 9,

Stock Market Today

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
Go toTop